CARDIFF AND VALE UNIVERSITY HEALTH BOARD. NOTES OF THE MEDICINES MANAGEMENT GROUP MEETING HELD ON WEDNESDAY 13 th JANUARY 2010
|
|
- Domenic Holmes
- 6 years ago
- Views:
Transcription
1 CARDIFF AND VALE UNIVERSITY HEALTH BOARD NOTES OF THE MEDICINES MANAGEMENT GROUP MEETING HELD ON WEDNESDAY 13 th JANUARY 2010 Present: Apologies: Dr Chris Jones (Chair), Dr Charles Allanby, Darrell Baker, Sam Ghofar, Dr Sharon Hopkins, Dr Tim Kinnaird, Dr Helen Lawton, Kate Morris, Mandy Rayani, Dave Roberts, Fiona Walker. Dr Kesh Baboolal, Paul Davies, Katie Norton. 1. Welcome and introductions Dr Chris Jones welcomed the members to the first meeting of the Medicines Management Group (MMG). He explained that the MMG will be officially classified as a group, not a committee, which will report to the Health Board s Quality & Safety Committee. The primary function of the MMG is to focus on safety and quality in the use of medicines; a further priority is to focus on cost effectiveness. 2. Presentation medicines management across the community Fiona Walker and Kate Morris gave a presentation to the group (encs). It was agreed that a Task & Finish group would be established to populate the spider diagram in time for the next meeting. The importance of LEAN pathway work across the health community was also noted. 3. Terms of Reference The membership of the Group was reviewed and the following were noted: The membership in the Terms of Reference was broadly agreed For the purposes of the MMG, Pharmacy representation in the absence of a Head of Department will be two pharmacists from Primary Care, two pharmacists from Secondary Care and a Community pharmacist There will be further discussions between the Medical Director and Director for Primary Care, Community & Mental Health regarding GP representation on the group It was agreed that a clinical pharmacologist will be included on the group. Professor Routledge has been approached for a nominee Dr Kesh Baboolal and Katie Norton will be approached to establish whether they will attend the group themselves or identify nominees Dr Sharon Hopkins or her nominee will represent Public Health Action KM With regard to other matters: The MMG will meet monthly for the first six months Other topics that potentially need to be included in the Terms of Reference are (a) audit (b) to co-ordinate responses to NICE/NCEPOD and (c) outcomes Roles and responsibilities will be reviewed in the light of the information that emerges from the spider diagram (see 2) It was agreed that item 12 from the draft Terms of Reference (amendment of the Terms of Reference) was deleted 1
2 Structures The Drug and Therapeutics Committee (DTC) appraises medicines and manages the Formulary for both Cardiff & Vale and Cwm Taf Health Boards. It was noted that the Welsh Assembly Government is investing in new systems for the appraisal of all medicines by AWMSG. The impact of this development on the DTC is uncertain and the position will be kept under review. It was suggested that the Medical Director might find it helpful to meet with Dr Martin Edwards (Chair of DTC) before the meeting of DTC on 11 th February. It was agreed that the Chairs of the four sub-groups did not need to be members of the MMG but they will be provided with copies of the agenda and minutes to ensure they are aware of what is being discussed and will have access as required It was noted that Dr Graham Shortland (Associate Medical Director for Quality & Safety) will Chair the new Thromboprophylaxis & Anticoagulation Group, which will report directly to the Quality & Safety Committee. It was proposed that the Chairmanship of the Safe Medication Practice Group should be discussed with Dr Shortland. 4. Legacy issues Prescribing Advisory Groups To ensure continuity of the prescribing incentive scheme To ensure continuity of the use of Scriptswitch messages To develop better alignment/ co-ordination of prescribing practices across Primary and Secondary Care (e.g. use of diclofenac) and between Divisions Trust Medicines Committee (TMC) The annual report of the TMC was noted together with the legacy issues. It was agreed that responsibility for NPSA Alert 18 (Oral anticoagulant therapy) will fall to the Thromboprophylaxis & Anticoagulation Group. An action plan will be developed for the other TMC legacy issues Medicines Information Card The recent seminal event involving the death of a patient on Clopidogrel was noted. The use of medicines information (green) cards has been reviewed in the light of this incident. Recommendations will be presented at the Nursing & Midwifery Board in late January. There will be further discussion under matters arising at the next meeting of the MMG.. / / MR 5. Cost Reduction Programme (CRP) Verbal report on CRPs There was no finance representative present to provide an update. Thalidomide (Dr Chris Fegan in attendance) Dr Fegan briefed the group on a proposal to switch from using licensed Thalidomide to unlicensed Thalidomide: this would save the Health Board ~ 250k per annum. A letter from the MHRA was tabled which specifically stated that there should be no unlicensed products supplied within the UK and cost is not a legally acceptable reason for the use of unlicensed Thalidomide. 2
3 In the light of the MHRAs letter it was concluded that unlicensed Thalidomide must not be used within the Health Board. 6. Drug & Therapeutics Committee The DTC met in September and November 2009 and made a number of recommendations regarding the formulary. A summary of these recommendations will be brought to the next meeting for consideration by MMG. 7. NICE/ HCD Group Dr Sharon Hopkins briefed members of the activities of this group. Dr Chris Jones will take over Chairmanship of this group. 8. Individual patient funding requests (Dr Fegan in attendance) There was a lively discussion about the different options for dealing with these requests both within the Health Board and across Health Boards. Dr Chris Jones informed members of his intention to devolve local decisions to the Divisions and that he would be Chairing Cardiff & Vale s Individual Patient Request Group for external patients and that Rob Mahoney is drafting a paper. Dr Fegan advised that clinicians supported a separate approval process for expensive drugs but questioned the expertise applied. Dr Jones advised that clinicians are responsible for financial aspects of care provided and will have to participate in the approval process in the future. 9. GMC report on prescribing errors Dave Roberts briefed members on the report and agreed to provide more comprehensive information on the GMC recommendations. This issue will be referred to Dr Tony Turley and Dr Steve Riley for discussion by the Medical & Dental Education Board. 10. NICE CG76 Medicines adherence Lack of time prevented a full discussion of this topic which will be carried forward to the next meeting. A local action plan is required. 11. Date of next meeting pm on 26 th February Venue to be confirmed. NotesMedsMgt13Jan10/dr/lg/s:dr 18 th January
4 CARDIFF AND VALE UNIVERSITY HEALTH BOARD NOTES OF THE MEDICINES MANAGEMENT GROUP MEETING HELD ON FRIDAY 26 th FEBRUARY 2010 Present: Apologies: Dr Chris Jones (Chair), Steve Gage, Alison Gerrard, Sam Ghofar, Dr Helen Lawton, Karen May, Dave Roberts, Fiona Walker. Dr Charles Allanby, Darrell Baker, Kate Morris, Mandy Rayani QUORATE? 1. Minutes of last meeting These were approved as an accurate record. 2. Matters arising Dr Chris Jones will meet with the Chair of the Drug & Therapeutics Committee shortly Dr Graham Shortland has agreed to chair the Safe Medication Practice Group and will consider attending MMG Dr Chris Jones will meet with Andrew Evans to discuss the NICE/ HCD Group Further work will be done on the spider chart, including seeking medical input. Dr Lawton offered to complete the scoring chart from a primary care perspective, secondary care input is also required to ensure a balanced view. The action plan for legacy issues will be brought to the next meeting An update on the medicines information card will be brought to the next meeting Drs Steve Riley and Tony Turley have been asked to consider the GMC Report on Prescribing Errors. Dr Chris Jones will seek to use the outcomes to inform a proposed new junior doctor induction programme. An update on Medicines adherence will be brought to the next meeting A report on shared care is being drafted. It will be shared with Primary Care colleagues prior to presentation at the next meeting Further consideration needs to be given to a process for managing Individual Patient Funding Requests for medicines 3. Terms of Reference Following the last meeting it had been agreed that there would be two GP representatives on the group an LMC representative and a clinical champion The Finance Director has nominated Alison Gerrard as his representative The importance of linking the MMG with Divisional Directors was noted. It was proposed that this might be achieved by Dr Mark Smithies representing Katie Norton and Dr Richard Evans representing Dr Kesh Baboolal The need to amend Roles and Responsibilities was noted but it was agreed that this should be done when the work on the spider chart was complete Action FW/KM ALL 1
5 4. Management of medicines across the healthcare community The Director General of NHS Wales has established 14 National Programme Boards to implement key elements of the AOF for NHS Wales. The National Programme Board for Medicines Management had its first meeting on 10 th February Dr Chris Jones was unable to attend and was represented by Dave Roberts, who briefed the group on the membership of the Board. Notes of the meeting had been circulated prior to MMG. Following the National Programme Board meeting an AOF for Medicines Management was submitted to the Health Board on 11 th February Section 9 reflected the discussion at the NPB: further discussions are required on other sections of the AOF. It was noted that the Pharmacy Locality Teams had also submitted documents on AOF targets 7 & 8. Dr Chris Jones indicated that he is accountable for medicines management strategy within the UHB and wished to have weekly meetings during March to agree an Operational Plan for medicines management Dr Jones indicated that he wished to have three patient safety essential targets or must do s. Two of these had already been identified bare below the elbows and thromboprophylaxis. It was agreed that the other priority should be to improve the exchange of information between secondary care and GP surgeries. Dr Jones informed the group that the Assembly s AOF states that there should be a 10% increase in the proportion of staff providing services in a community setting, to be achieved between 2010 to 2013.Chief Executive expected 10% of the hospital based workforce to be transferred to primary care. Dave Roberts agreed to lead a Task & Finish Group to explore this requirement and to establish how better links could be established between pharmacists and GP surgeries. / 5. Cost Reduction Programme (CRP) Alison Gerrard informed the group that the Pharmacy Locality Teams were on target to make savings of ~ 1.25m on the primary care drug budget of 75m and the Pharmacy Directorate was on target to make savings of ~ 1m on the secondary care drug budget of 45m. Dr Jones expressed his thanks to all involved. 6. AWMSG The recent notification about the AWMSG appraisals carried out in December was discussed. Dr Jones noted that Ranolazine and Degarelix had been rejected by AWMSG and expressed his wish to ensure these drugs were not used within the UHB. 7. Drug & Therapeutics Committee (Mrs Rowena McArtney in attendance) The group received a report on the medicines appraised by the Drug & Therapeutics Committee in September and November The majority of the recommendations were neither costly nor controversial and the recommendation to add them to the Formulary was accepted. The one exception was Alitretinoin, an expensive new retinoid that has been approved by NICE: this will be added to the formulary but its use will be monitored through the NICE/ HCD Group. Alison Gerrard noted that there continues to be a need for evaluation of the financial impact of formulary /RMcA 2
6 changes. The NICE/ HCD group may perform this function for NICE and AWMSG appraisals. The group noted NICE Clinical Guidelines number 91, which drew attention to the cardio toxicity of Dosulepin. It was agreed that Dr Jones would write to medical staff drawing their attention to these guidelines and requesting them to switch patients to a less toxic alternative. 8. NPSA Rapid Response Reports Safer Lithium therapy. The two pharmacists who will lead on this are Wendy Davies (Secondary Care) and Anthony Hall (Primary Care) Vaccine Cold Storage. The leads on this are Wendy Davies (Secondary Care) and Sian Rowlands (Primary Care) The UHBs current arrangements are that the Nurse Director is responsible for nominating leads for NPSA Alerts and RRRs. The consensus was that it would be more appropriate for Dr Jones to undertake that responsibility for medicines. FW/ 9. Prescribing in paediatrics (Dr Dave Tuthill) Dr Tuthill presented the work which he had undertaken over the course of the last 5 years. The deficiencies in junior doctors prescribing had been identified and quantified. A range of measures had been introduced to improve junior doctors prescribing. This included consultants and pharmacists providing training for junior doctors and under graduates: training in prescribing was provided and the trainees were subsequently tested on their prescribing abilities. Subsequent monitoring had demonstrated that these measures had substantially reduced prescribing errors. In the ensuing discussion it was agreed that Dr Tony Turley and Dr Steve Riley would be asked to include Dr Tuthill in their discussions on how to support the proposed new junior doctor induction programme, including implementation of the recommendations of the GMC Report on Prescribing Errors. 10. Update on controlled drugs This item was deferred until the next meeting 11. Prescribing for staff The current policy and procedure on prescribing for staff needs updating. Members were asked to give their comments to Dave Roberts. ALL 12. Date of next meeting on Thursday 25 th March in the meeting room in the Clinical Research Facility at UHW. NotesMedsMgt26Feb10/dr/lg/s:dr 2 nd March
7 CARDIFF AND VALE UNIVERSITY HEALTH BOARD NOTES OF THE MEDICINES MANAGEMENT GROUP MEETING HELD ON THURSDAY 25 th MARCH 2010 Present: Apologies: Dr Chris Jones (Chair), Dr Charles Allanby, Darrell Baker, Adele Gittoes, Dr Sharon Hopkins, Dr Helen Lawton, Karen May, Kate Morris, Mandy Rayani, Dave Roberts Alison Gerrard, Sam Ghofar, Dr Tim Kinnaird, Dr John Thompson 1. Minutes of last meeting These were approved as an accurate record. 2. Matters arising Dr Jones had met with the Chair of the Drug & Therapeutics Committee (DTC) and was impressed with the work being undertaken. He indicated that the DTC would continue to meet for the foreseeable future. Dr Jones indicated that the NICE/ HCD Group will be disbanded as he will be drafting proposals for a new Clinical Effectiveness Steering Group and process for Individual Funding Requests for medicines. In future all NICE/ AWMSG issues will be dealt with at MMG: a Haematology representative will be required on the group. An update on the spider chart will be brought to the next meeting. The action plan for legacy issues will be brought to the next meeting An update on the medicines information card will be brought to the next meeting The uhb had agreed that its top three patient safety issues for 2010/11 would be (a) Thromboprophylaxis, (b) radical improvement in hand washing and reduction in the incidence of C diff and (c) prevention of pressure damage. Action KMo Operational Plan The Health Board needs to make savings of 75m on its budget of approximately 1bn. The medicines management contributions to this target have been identified as 4.5m on general medicines expenditure and a further 2m on NICE medicines. Local GPs had recently indicated that there was limited awareness of the Joint Formulary and suggested that savings of 10% could be made on medicines expenditure in primary care ( 75m). It was agreed that action is required to prevent medical staff work arounds to the Formulary. Dr Sharon Hopkins expressed concern about the deliverability of the NICE target, which she regarded as very high risk. The Operational Plan for Medicines Management had been circulated prior to the meeting. Kate Morris highlighted the following elements of the plan to the group: The growth in prescription numbers in primary care in Cardiff and Vale exceeds the national average, which puts additional pressure on the budget The AOF sets out a number of prescribing indicators for primary care 1
8 and performance during 2009/10 was generally good. The CRP savings achieved on medicines during 2009/10 was 2.2m The financial strategy for 2010/11 is forecasting total expenditure on medicines and the uhb s pharmacy staff will be 137m. The CRP target for 2010/11 is 6.5m The Operational Plan contains a mix of traditional and transformational schemes. These schemes will be subject to formal project management and an electronic dashboard is being developed to monitor progress. The importance of establishing good links between clinicians and clear accountability for each of the schemes. Primary care schemes will be signed off by Dr Mark Smithies and secondary care schemes will need to be signed off by the appropriate Divisional Director. There was a lengthy discussion about the Operational Plan and the following points were noted: Concern was expressed that some consultants request GPs to prescribe non-formulary medicines as a work around the control mechanisms that are in place in secondary care. Dr Jones indicated his willingness to deal with this issue. The existing contract rewards community pharmacists for the number of items that they dispense. This can be a perverse incentive as it fails to reward good pharmaceutical care. There was general agreement that a more modern contract could improve medicines management. The National Programme Board for Medicines Management has advised WAG that this needs to be addressed The group was informed that the Vale locality is piloting a scheme which rewards community pharmacists for stopping unnecessary treatment. There are three sizeable elements of the Operational Plan where savings have yet to be quantified: these are (a) NICE (b) the total procurement system for dressings and (c) clinical review of the use of analgesic patches 3. Terms of Reference Following Alison Gerrard s appointment to a new post the Finance Director has nominated Adele Gittoes as his representative Dr Jones had written to Katie Norton and Dr Kesh Baboolal to propose that they be represented by Dr Mark Smithies and Dr Richard Evans respectively. The need to amend roles and responsibilities was noted but it was agreed that this should be done when the work on the spider chart was complete. The terms of reference for the Safe Medication Practice Group were approved subject to a number of minor amendments. 4. Antimicrobial Group (Dr R Howe in attendance) Dr Howe shared his views on anti-microbial stewardship with the group. These were: Antibiotic resistance is becoming a problem particularly in primary care, where there is growing resistance to E coli, the single most common cause of urinary tract infections and bloodstream infections. The growing resistance to trimethoprim means that more expensive antibiotics need to be used. The wide spread use of antibiotics is one of 2.
9 the factors that has stimulated resistance Antibiotics can cause adverse effects, which means that they should not be used unnecessarily Research has shown that approximately 20% of antibiotic use is inappropriate. This may be because treatment was not indicated in the first place, has been continued when no longer necessary, a sub-optimal agent was used, or an inappropriate dose was used. This is a problem in both primary and secondary care. The old Cardiff & Vale NHS Trust established an Antimicrobial Group to address these issues in Membership of the group comprised microbiologists, other medical staff and pharmacists. A range of measures were introduced to improve antimicrobial prescribing. These included: A Trust policy on antimicrobials, which required all directorates to develop their own procedures for the use of antimicrobials An antibiotic credit card which summarised appropriate use of antibiotics in the medicine directorate and which is issued to junior medical staff Engagement of medical staff proved challenging in some directorates and the credit card now needs to be updated to reflect changes in the recommendations on the use of antibiotics. It was agreed that: Dr Howe would draft terms of reference for a new Antimicrobial Group and update the credit card for the medicine directorate, which would be paid for by the Medical Director. Dr Howe would liaise with primary care to arrange presentations at their education and training sessions. Dr Jones would liaise with Divisional Directors to inform them that antibiotic procedures are required for each of their areas and those procedures need to be implemented by July RH RH 5. C diff outbreak Dr Jones informed the group that the hospitals in Cardiff and Vale had a high incidence of C diff compared with other hospitals in Wales. In February there were 106 new cases with 80 new cases projected for March: the Medicine Directorate has the highest number of cases. The treatment of C diff normally requires approximately 19 days as an inpatient. The medical and nurse directors are jointly chairing the C diff action group which meets monthly. In the ensuing discussion a number of suggestions were made including the restriction of certain antibiotics (e.g. cefuroxime). It was agreed that Dr Jones, Dr Howe and Dave Roberts would meet with Divisional Directors to discuss the way forward and the need for better engagement of medical staff. 6. Management of medicines across the healthcare community The notes of the National Programme Board for Medicines Management had been circulated prior to the meeting and certain elements had been discussed under the Operational Plan. Members were invited to seek further information from Dave Roberts. The first meeting of the Task & Finish Group on pharmacy staffing will be 3
10 held during April. Nominations had been received from Katie Norton and Kesh Baboolal. Nominations will also be sought from Nursing and HR. The paper on medicines adherence (NICE CG76) was discussed. It was agreed that Darrell Baker would look at the NLIAH material to support implementation of this guidance. Dr Jones would arrange for it to be put on the agenda of the new Clinical Effectiveness Steering Group and for Peter Durning to be consulted for his views. The report on shared care was discussed. It was agreed that: An action plan would be brought to the next meeting of MMG and that compliance with the action plan would be monitored by MMG Complaints from GPs should be sent to Dr Graham Shortland 7. Drug & Therapeutics Committee (DTC) There was insufficient time to discuss the recommendations from the DTC meeting in February: this item was deferred to the next meeting. 8. NPSA Rapid Response Reports Omitted or delayed doses in hospital The action plan was noted and it was agreed that Jenny Jones would be asked to consider adding this to the annual audit programme. 9. Update on controlled drugs This item was not discussed. 10. Date of next meeting 9am 11am on Weds 21 st April 2010 in the meeting room in the Clinical Research Facility at UHW. NotesMedsMgt25Mar10/dr/lg/s:dr 31 st March
11 CARDIFF AND VALE UNIVERSITY HEALTH BOARD NOTES OF THE MEDICINES MANAGEMENT GROUP MEETING HELD ON THURSDAY 21 st APRIL 2010 Present: Apologies: Dr Chris Jones (Chair), Darrell Baker, Sam Ghofar, Adele Gittoes, Dr Sharon Hopkins, Dr Tim Kinnaird, Dr Helen Lawton, Kate Morris, Mandy Rayani, Dave Roberts, Dr Mark Smithies, Dr John Thompson, Fiona Walker Dr Charles Allanby, Lynne Aston, Dr Robin Howe Karen May, 1. Minutes of last meeting These were approved as an accurate record, with the exception that Fiona Walker had sent her apologies. 2. Matters arising The need for an official minute taker was reiterated. Terms of Reference for the Antimicrobial Group will be brought to the next meeting. Membership will include Primary Care representation. Copies of the antimicrobial credit card will be made available to fourth and fifth year medical students 3. TMC legacy issues The draft TMC action plan was discussed and the following were noted: All actions need to be taken forward as part of a whole system approach and not as separate actions for primary and secondary care The cytotoxic chemotherapy group will be asked to broaden its remit and to consider wider issues. Robert Williams will be invited to join the Medicines Management Group and to produce a merged system for recording, responding to and monitoring of NPSA Alerts and RRRs. The use of the existing newsletters for primary care and secondary care needs to be reviewed to improve cross fertilisation. Medicines management meetings need to conclude with what needs to be communicated. The addresses of all medical staff are required to ensure that the prescribing newsletters can be sent to them. Sources of this information might include Andrew Cooper (GPs), Carolyn Jones (hospital doctors) and the deanery. Action / RH /JT /MS /KM 4. Operational Plan Dr Jones expressed his thanks to colleagues for all the hard work that had gone in to producing the PID and action plan and noted that the work to date was as good as anything that had been produced within the uhb. He also stated that the target had now been increased to 8m, because GPs believe that 10% can be saved on their expenditure, through better compliance with the formulary Adele Gittoes briefed the group on the PID and action plan and highlighted that the action plan will be used to monitor progress at monthly meetings of the CRP Operational Group, which will report to MMG. The need for engagement of Divisional Directors in secondary care was also noted. Adele Gittoes informed the group that the CRP schemes identified in secondary care would have to be allocated to directorates before meetings with divisional directors/ managers had taken place: these meetings will be taking place during April/ May. Dr Jones acknowledged that the / 1
12 allocation of the savings would have to precede these meetings to comply with Finance s budgetary processes. The original requirements for medicines management were savings on 2m on NICE medicines and 4.5m on other medicines: to date the savings identified amount to 3.4m for other medicines. Attention was drawn to three resource intensive areas of the plan the NICE review, the total purchasing scheme for dressings and the review of the use of analgesic patches. The savings for the latter two schemes have yet to be quantified. Dr Jones explained that total CRPs identified to date amounted to 45m of the 80m target for the uhb. Additional measures (plan B) are required in all areas to deliver the additional savings. Adele Gittoes expressed concern that there unlikely to be enough pharmacy resources to deliver an expanded medicines programme which will deliver the full 8m savings. This was acknowledged by Dr Jones. There was a lengthy discussion about the use of non-formulary drugs and the following were agreed: The primary care representatives will draft a letter for Dr Jones to send to all hospital doctors. The letter will explain the need to comply with the formulary. Steps will be taken to ensure that junior medical staff receive key messages about the formulary and first line medicines, possibly through the induction process. A system will be developed to identify the inappropriate recommendation of nonformulary drugs by consultants and to bill their directorates for those drugs. An action plan will be brought to the next MMG meeting. Corporate Governance need to discuss the proposal that private prescriptions should not be sent to GPs asking them to prescribe medicines on the NHS The following additional measures were also noted: Membership of the CRP Operational Group needs to be expanded to include representation from Divisional Directors in primary care and secondary care Cardiology s approach to the cost effective management of hypertension should be (a) promoted across the uhb and (b) shared with other areas as an example of good practice that they could adopt GPs and consultants need to be contacted to ask for their ideas to contain expenditure Concern was expressed that the existing Prescribing Incentive Scheme rewards those practices that are bad prescribers rather than rewarding good prescribers The Good Prescribing Guide needs to be made available to fourth and fifth year medical students. The sixth edition of the Guide will be published in the summer of There may be the opportunity for better clinical care, which produces financial savings, by reviewing individual patients prescriptions in primary care 5. Medicines management across the healthcare community (i) Update on NPC toolkit The results of the audit against the NPC toolkit were noted. On a rating scale of 1 6 (where 1 = poor and 6 = excellent) the majority of the uhbs medicines management processes scored between 2 and 3. The consensus was that this was a very useful baseline for the new organisation. There was a lengthy discussion on how best to move forward. The Shared Care Sub-group is currently developing an action plan: it was agreed that the Sub-group would check the action plan against the tool-kit prior to implementation. The membership of the sub-group may need to be expanded to achieve this. HL/FW /JT HL/FW/ SH /SH /MS TK KM/MS /JT T&F Group. /FW 2
13 (ii) Strategic Task & Finish Group (TFG) The terms of reference for the TFG were briefly discussed and it was agreed that (a) the remit needed to include secondary care, primary care and the community and (b) finance and GP representatives would be identified. The first meeting of the group will be on 29 th April. 6. Recommendations from Drug & Therapeutics Committee All of the recommendations were accepted as none carried significant financial risk. The recommendation for Loperamide should have been that the tablets should be added to the Formulary as a second line product. This recommendation was approved. Information about these decisions will be shared with GPs and hospital doctors via the appropriate newsletters Adele Gittoes agreed to cost future recommendations prior to MMG meetings /KM /AG 7. Papers noted C difficile Improvement Plan AWMSG recommendations 8. Individual funding requests Dr Sharon Hopkins presented the draft Policy for making decisions on individual requests for treatment (IRT). Meetings of the IRT panel will take place twice monthly with two parts to each meeting (a) requests for treatments/ procedures not normally undertaken by the uhb and requests for treatment outside the uhb and (b) requests for medicines not normally provided by the uhb. Input from expert doctors and pharmacists will be required for (b). Requests to the IRT panel will need to be signed off at divisional level before going to the panel, which will not have a separate budget. Thus, the costs of approvals by the IRT panel will be borne by the divisions. Dr Hopkins invited comments on the draft policy, which is due to be considered by the Health Board on 11 th May. ALL 9. Date of next meeting 2pm 4pm on Weds 19 th May 2010 in the meeting room in the Clinical Research Facility at UHW. NotesMedsMgt21Apr10/dr/lg/s:dr 21 st April
PROGRESS WITH NPSA ALERT IMPLEMENTATION
AGENDA ITEM 3.5 4 th September 2013 PROGRESS WITH NPSA ALERT IMPLEMENTATION Executive : Executive Director of Nursing Author: Assistant Director of Patient Safety & Quality Contact Details for further
More informationPrimary Care Prescribing Cardiff and Vale University Health Board. Issued: December 2013 Document reference: 447A2013
Primary Care Prescribing Cardiff and Vale University Health Board Issued: December 2013 Document reference: 447A2013 Status of report This document has been prepared for the internal use of Cardiff and
More informationWELSH AUDIT OFFICE REPORT ON PRIMARY CARE PRESCRIBING
AGENDA ITEM 2.5 28 January 2014 WELSH AUDIT OFFICE REPORT ON PRIMARY CARE PRESCRIBING Lead Responsibility: Medical Director Author: Clinical Board Pharmacist, Primary Community Intermediate Care Clinical
More informationMINUTES OF THE MEDICINES MANAGEMENT GROUP MEETING
MINUTES OF THE MEDICINES MANAGEMENT GROUP MEETING Date & Time of Meeting: Venue: Wednesday 8 th February 2012 @ 1.30pm Boardroom, Glangwili Hospital, Carmarthen Present: In Attendance: Dr. Carol Llewellyn-Jones,
More informationAGENDA ITEM 17b Annex (i)
QUALITY AND PATIENT SAFETY COMMITTEE Minutes of the meeting held on 10 th April 2014 Welsh Health Specialised Services Committee Offices Unit 3a, Van Road Caerphilly Business Park Caerphilly CF83 3ED Present
More informationWELSH RENAL CLINICAL NETWORK TERMS OF REFERENCE
INTRODUCTION WELSH RENAL CLINICAL NETWORK TERMS OF REFERENCE In accordance with WHSSC Standing Order 3, the Joint Committee may and, where directed by the LHBs jointly or the Welsh Government must, appoint
More informationQUALITY COMMITTEE. Terms of Reference
QUALITY COMMITTEE Terms of Reference CONSTITUTION 1. The Board of Directors approved the establishment of the Quality Committee (known as the Committee in these terms of reference) for the purpose of:
More informationCLINICAL GOVERNANCE AND QUALITY COMMITTEE. Final - Terms of Reference - Final
CLINICAL GOVERNANCE AND QUALITY COMMITTEE Final - Terms of Reference - Final CONSTITUTION 1. The Board of Directors approved the establishment of the Clinical Governance and Quality Committee (known as
More informationVELINDRE NHS TRUST. Trust Procedure PROCEDURE FOR THE IMPLEMENTATION OF NATIONAL INSTITUTE OF HEALTH & CLINICAL EXCELLENCE (NICE) GUIDANCE
Clinical Excellence (NICE) Guidance VELINDRE NHS TRUST Trust Procedure Black 21 PROCEDURE FOR THE IMPLEMENTATION OF NATIONAL INSTITUTE OF HEALTH & CLINICAL EXCELLENCE (NICE) GUIDANCE Lead: Lisa Heydon-Mann
More informationMEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY
MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY NHS employees and contractors link with the pharmaceutical industry in a number of ways, as a source of information, through the receipt
More informationBabylon Healthcare Services
Babylon Healthcare Services Limited Babylon Healthcare Services Ltd. Inspection report 60 Sloane Avenue London SW3 3DD Tel: 0207 1000762 Website: www.babylonhealth.com Date of inspection visit: 4 July
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationBest Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP
Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse
More informationUKMi and Medicines Optimisation in England A Consultation
UKMi and Medicines Optimisation in England A Consultation Executive Summary Medicines optimisation is an approach that seeks to maximise the beneficial clinical outcomes for patients from medicines with
More informationUnlicensed Medicines Policy Document
Unlicensed Medicines Policy Document Effective: February 2002 (Intranet 2006) Review date: February 2007 A. Introduction In order to ensure that medicines are safe and effective the manufacture and sale
More informationUncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES
Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company
More informationItem number and heading Related paper/s Notes and actions Action by 16/29
OPEN BUSINESS Minutes of WPB Board Meeting held on Thursday 28 April 2016 Present: Suzanne Scott-Thomas (Chair); Paul Harris (PH), Vice Chair part attendance; Gareth Holyfield (GH); Phil Parry (PP); Richard
More informationApologies for absence were noted from Ms Claire Dobson, Dr I Gourley, Dr J Kennedy, Professor S McLean, Mr I Mohammed.
CONFIRMED MINUTES OF THE MEETING OF THE FIFE DRUGS AND THERAPEUTICS COMMITTEE HELD AT 12.30PM ON WEDNESDAY 4 OCTOBER 2017 IN MEETING ROOM 2, WARD 6, VICTORIA HOSPITAL, KIRKCALDY. Present: Dr Frances Elliot
More informationQuality, Safety & Experience (QSE) Committee. Minutes of the Meeting Held on Wednesday 29 th March 2017 in the Boardroom, Carlton Court, St Asaph
1 Minutes QSE Public 29.3.17 V1.0 Present: Quality, Safety & Experience (QSE) Committee Minutes of the Meeting Held on Wednesday 29 th March 2017 in the Boardroom, Carlton Court, St Asaph Mrs Margaret
More informationAppendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH
Appendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH All prescribers and their managers/professional leads should ensure
More informationTitle: Replacement of the Commissioning Advisory Forum Agenda Item: 9
Meeting of Bristol Clinical Commissioning Group To be held on Tuesday, 2 July 2013 commencing at 1.30 pm in the BAWA Centre Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9 1 Purpose
More informationMs Lyndsey Hands, Graduate Trainee (observer) Mrs Sandra MacDonald (minutes) ACTION
CONFIRMED MINUTES OF THE MEETING OF THE FIFE DRUGS AND THERAPEUTICS COMMITTEE HELD AT 12.30PM ON WEDNESDAY 16 AUGUST 2017 IN MEETING ROOM 2, WARD 6, VICTORIA HOSPITAL, KIRKCALDY. Present: Mrs Evelyn McPhail
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationReview of Management Arrangements within the Microbiology Division Public Health Wales NHS Trust. Issued: December 2013 Document reference: 653A2013
Review of Management Arrangements within the Microbiology Division Public Health Issued: December 2013 Document reference: 653A2013 Status of report This document has been prepared for the internal use
More informationNLG(13)250. DATE 30 July Trust Board of Directors Part A. Dr Liz Scott, Medical Director REPORT FROM
NLG(13)250 DATE 30 July 2013 REPORT FOR Trust Board of Directors Part A REPORT FROM Dr Liz Scott, Medical Director CONTACT OFFICER Dr Liz Scott, Medical Director SUBJECT Infection Control Committee Minutes
More informationRadiology CPG Annual Report for Quality, Safety and Experience Sub-Committee- April 2015
Radiology CPG Annual Report for Quality, Safety and Experience Sub-Committee- April 2015 1. Purpose of report To provide assurance to the QSE sub-committee of the Radiology CPG s commitment to quality,
More informationAgenda Item 3.3 IMPLEMENTATION OF SETTING THE DIRECTION - WHOLE SYSTEMS CHANGE PROGRESS UPDATE
FOR INFORMATION UHB Board Meeting: 17 January 2012 IMPLEMENTATION OF SETTING THE DIRECTION - WHOLE SYSTEMS CHANGE PROGRESS UPDATE Report of Paper prepared by Executive Summary Director of Public Health
More informationAppendix 10a SBAR REPORT MARCH 2010 FREE TO LEAD FREE TO CARE, EMPOWERING WARD SISTER / CHARGE NURSE SITUATION
SBAR REPORT MARCH 2010 FREE TO LEAD FREE TO CARE, EMPOWERING WARD SISTER / CHARGE NURSE SITUATION The purpose of this report is to inform the Board members of the current position and progress of Cwm Taf
More informationAgenda Item 5.1 Appendix 11 CWM TAF UNIVERSITY LOCAL HEALTH BOARD
CWM TAF UNIVERSITY LOCAL HEALTH BOARD MINUTES OF THE MEETING OF THE PRIMARY CARE COMMITTEE HELD ON 26 AUGUST 2015 AT YNYSMEURIG HOUSE, ABERCYNON PRESENT: Professor D Mead Mr J Palmer Mr G Bell Cllr C Jones
More informationSouth Gloucestershire Clinical Commissioning Group Improving the Patient Experience Forum Meeting
South Gloucestershire Clinical Commissioning Group Improving the Patient Experience Forum Meeting Date: 8 th February 2017 Time: 10am-12:30pm Location: The Batch, Warmley, Bristol MINUTES IPEF members
More informationImproving compliance with oral methotrexate guidelines. Action for the NHS
Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication
More informationPROCEDURE FOR THE SAFE HANDLING AND ADMINISTRATION OF INTRATHECAL CHEMOTHERAPY
Reference Number: UHB209 Version Number: 2 Date of Next Review: 15/12/2019 Previous Trust/LHB Reference Number: TMC372 PROCEDURE FOR THE SAFE HANDLING AND Introduction and Aim 1. INTRODUCTION This procedure
More informationReport to the Trust Board
Report to the Trust Board Southport & Ormskirk Hospital NHS Trust Date of Board Meeting 26 January 2011 AGENDA ITEM: 7c Title of Report EXECUTIVE SUMMARY of the REPORT (please outline the purpose of this
More informationNew v1.0 Date: Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee
Clinical Pharmacy Services: SOP Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key Words:
More informationPharmacist (Palliative Care) December 2014 Page 1
Job Profile Job Title: Department: Main Location: Hospice Palliative Care Pharmacist 7 NHS (8SRC) Less than full time(0.8) Full time equivalent around 36,300 Head of Clinical Services 1. Main Purpose of
More informationInformation shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.
THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes 1.1 Short title Medicines
More informationSection Title. Prescribing competency framework Catherine Picton, Lead author
Prescribing competency framework Catherine Picton, Lead author What is in this presentation Context Uses of the competency framework Scope of the updated prescribing competency framework Introduction to
More informationPOWYS TEACHING HEALTH BOARD PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE
POWYS TEACHING HEALTH BOARD Meeting 04/12/12 Present: PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE Minutes of the meeting held on Thursday, 06 September 2012 at 09.30am in Training Room 1, Bronllys
More informationReview of Terms of Reference of Quality Assurance Committee
Review of Terms of Reference of Quality Assurance Committee Governing Body meeting 3 May 2018 H Author(s) Sponsor Director Purpose of Paper Sue Laing, Corporate Services Risk and Governance Manager Mandy
More informationNursing Home Antimicrobial Stewardship Guide Implement, Monitor, & Sustain a Program
Nursing Home Antimicrobial Stewardship Guide Implement, Monitor, & Sustain a Program Toolkit 1. Start an Antimicrobial Stewardship Program Tool 5. Draft Policies and Procedures for the Antimicrobial Stewardship
More informationProgress in the rational use of medicines
SIXTIETH WORLD HEALTH ASSEMBLY A60/24 Provisional agenda item 12.17 22 March 2007 Progress in the rational use of medicines Report by the Secretariat 1. The present report provides a summary of the major
More informationMedicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationOxfordshire Primary Care Commissioning Committee
Oxfordshire Clinical Commissioning Group Oxfordshire Primary Care Commissioning Committee Date of Meeting: 6 March 2018 Paper No: 6 Title of Paper: Prescribing Incentive Scheme 2018-19 Proposal Paper is
More informationCare Home support and medicines optimisation: Community Pharmacy National Enhanced Service
Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service 1 1. Introduction Back in 2006 the National Service Framework for Older People in Wales 1 highlighted the problem
More informationNorth School of Pharmacy and Medicines Optimisation Strategic Plan
North School of Pharmacy and Medicines Optimisation Strategic Plan 2018-2021 Published 9 February 2018 Professor Christopher Cutts Pharmacy Dean christopher.cutts@hee.nhs.uk HEE North School of Pharmacy
More informationPrevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process
More informationRHONDDA CYNON TAFF TEACHING LOCAL HEALTH BOARD. Minutes from the meeting held on: Voluntary Sector Representative
RHONDDA CYNON TAFF TEACHING LOCAL HEALTH BOARD Minutes from the meeting held on: Wednesday 9 th September 2009 Present: Dr CDV Jones Chairman Mrs A Lagier Acting Chief Executive Mrs L Williams Nurse Director
More informationCARDIFF AND THE VALE UNIVERSITY HEALTH BOARD. Stakeholder Reference Group Meeting
CARDIFF AND THE VALE UNIVERSITY HEALTH BOARD Stakeholder Reference Group Meeting 9.00 11.30 Tuesday 24th September 2013 Meeting Room 1, Planning, Estates and Operational Services Department, 2nd Floor,
More informationRegional Medicines Optimisation Committees
Regional Medicines Optimisation Committees Operating Model First Edition, April 2017 NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients and Information Nursing Trans.
More informationRESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO ACCESS TO MEDICAL TECHNOLOGIES IN WALES
Recommendations 1, 2, 3 1. That the Minister for Health and Social Services should, as a matter of priority, identify means by which a more strategic, coordinated and streamlined approach to medical technology
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT 1. Date of Governing Body Meeting 16 th November 2017 2. Title of Report: 3. Key Messages: BUPA ceased to be the registered provider of Crawfords Walk Nursing Home in October. The
More informationEXECUTIVE MEDICAL DIRECTOR JOB DESCRIPTION. Medical Education Leads Clinical Directors (professional leadership) Director of Clinical Audit
EXECUTIVE MEDICAL DIRECTOR JOB DESCRIPTION Job Title: Accountable to: Responsible for: Executive Medical Director Chief Executive Director of Research & Development Medical Education Leads Clinical Directors
More informationMedicines Management in Community Hospitals Powys Teaching Health Board. Audit year: Issued: September 2015 Document reference: 450A2015
Medicines Management in Community Hospitals Powys Teaching Health Board Audit year: 2014-15 Issued: September 2015 Document reference: 450A2015 Status of report This document has been prepared as part
More informationNon Medical Prescribing Policy
Non Medical Prescribing Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces:
More informationHealthcare Support Workers. Administration of Medicines For Specified Children with Complex Needs in the Community
Healthcare Support Workers Administration of Medicines For Specified Children with Complex Needs in the Community Author: Children s Community Nursing Team Child Health This document in principle matches
More informationNHS WALES INFORMATICS MANAGEMENT BOARD
NHS WALES INFORMATICS MANAGEMENT BOARD Draft minutes of part 1 of the meeting Wednesday 28 April 2016 14:00 15:00 Attendees: Andrew Goodall (AGD), Chair - Welsh Government Steve Ham (SH) - Velindre NHS
More information2.00pm, Thursday, 16 November 2017 Caer Suite, Mid and West Wales Fire and Rescue Service HQ, Carmarthen
2.00pm, Thursday, 16 November 2017 Caer Suite, Mid and West Wales Fire and Rescue Service HQ, Carmarthen MINUTES Present Name Cllr. Emlyn Dole (Vice-chair) Ruth Mullen Chief Inspector Steve Thomas Anna
More informationNPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing
NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix
More informationSafer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS
Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the
More informationManagement of Reported Medication Errors Policy
Management of Reported Medication Errors Policy Approved By: Policy & Guideline Committee Date of Original 6 October 2008 Approval: Trust Reference: B45/2008 Version: 4 Supersedes: 3 February 2015 Trust
More informationSouth Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Policy for Medicines Reconciliation on Admission and on
More informationNHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 12. Date of Meeting: 23 rd March 2018 TITLE OF REPORT:
NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 12 Date of Meeting: 23 rd March 2018 TITLE OF REPORT: AUTHOR: PRESENTED BY: PURPOSE OF PAPER: (Linking to Strategic Objectives)
More informationMinor Oral Surgery Service Reconfiguration
Minor Oral Surgery Service Reconfiguration 1 Introduction The purpose of this report is to inform the Board on the status of the Minor Oral Surgery Service Reconfiguration programme and request approval
More informationSouth East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide
South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide 1. Introduction 1.1 This policy has been developed by the South East London Clinical Commissioning
More informationPHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK
PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course
More informationNHS BARNSLEY. Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House.
Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House. PRESENT: Dr M Ghani (Chair) Medical Director Barnsley CCG (Designate) Dr
More informationWelsh Government Response to the Report of the National Assembly for Wales Public Accounts Committee Report on Unscheduled Care: Committee Report
Welsh Government Response to the Report of the National Assembly for Wales Public Accounts Committee Report on Unscheduled Care: Committee Report We welcome the findings of the report and offer the following
More informationRUSI/STFC Workshop. Tackling Antimicrobial Resistance: Identifying Future Research Themes. 6 February 2013
RUSI/STFC Workshop Tackling Antimicrobial Resistance: Identifying Future Research Themes 6 February 2013 Programme 0830 Registration and Coffee 0900 Welcome and introduction Dr Bryan Edwards, Science and
More information3. Minutes, action log and attendance list of Last Meeting and Matters Arising. The minutes of the March meeting were accepted as accurate.
South East London Area Prescribing Committee (APC) 23 June 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests, either
More informationWEST HERTFORDSHIRE HOSPITALS NHS TRUST TRUST LEADERSHIP EXECUTIVE COMMITTEE
Trust Board 25 July 2013 Part 1 Item 46.5c/13 WEST HERTFORDSHIRE HOSPITALS NHS TRUST TRUST LEADERSHIP EXECUTIVE COMMITTEE Minutes of the TLEC Meeting held on Thursday 4 July 2013 Lecture Room 2, Medical
More informationCHILD AND ADOLESCENT MENTAL HEALTH SERVICES
AGENDA ITEM 7.5 CHILD AND ADOLESCENT MENTAL HEALTH SERVICES Executive Lead: Director of Public Health Author: Rose Whittle CAMHS Commissioning Lead Contact Details for further information: Rose Whittle
More informationCLINICAL GOVERNANCE AND QUALITY COMMITTEE Terms of Reference
CLINICAL GOVERNANCE AND QUALITY COMMITTEE Terms of Reference CONSTITUTION 1. The Board of Directors approved the establishment of the Clinical Governance and Quality Committee (known as the Committee in
More informationClinical Skills and Simulation Strategy
Clinical Skills and Simulation Strategy August 2010 Contents 2 Forward... 3 Definitions... 4 Introduction... 4 Regional context... 5 Aim... 6 Action Plan... 6 Quality Standards... 7 Regional investment
More informationImproving patient safety and infection. Patient Safety Forum Dr J Coleman 1 ELECTRONIC PRESCRIBING AND CLINICAL DECISION SUPPORT (CDS)
Improving Patient Safety and Infection Control Through Electronic Prescribing Dr Jamie Coleman Senior Lecturer in Clinical Pharmacology / Honorary Consultant Physician The brief Clinical computing technologies
More informationDraft Minutes. Agenda Item: 16
Meeting of Bristol Clinical Commissioning Group Quality and Governance Committee Held on 17th December 2013 At 9:00am in Clinical Commissioning Group Meeting Room Agenda Item: 16 Draft Minutes Present:
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Principles Interim Process and Methods of the Highly Specialised Technologies Programme 1. Our guidance production processes are based on key principles,
More informationPATIENT ACCESS POLICY (ELECTIVE CARE) UHB 033 Version No: 1 Previous Trust / LHB Ref No: Senior Manager, Performance and Compliance.
Reference No: PATIENT ACCESS POLICY (ELECTIVE CARE) UHB 033 Version No: 1 Previous Trust / LHB Ref No: Trust 364 Documents to read alongside this Policy. Ministerial Letter EH/ML/004/09 WAG Rules for Managing
More informationHEI self-assessment. Completing the self-assessment - Guidance to NHS boards
HEI self-assessment Completing the self-assessment - Guidance to NHS boards INTRODUCTION This document should be read in conjunction Healthcare Improvement Scotland healthcare associated infection (HAI)
More informationMedicine Reconciliation FREQUENTLY ASKED QUESTIONS NATIONAL MEDICATION SAFETY PROGRAMME
Medicine Reconciliation FREQUENTLY ASKED QUESTIONS NATIONAL MEDICATION SAFETY PROGRAMME The Process What is medicine reconciliation? Medicine reconciliation is an evidence-based process, which has been
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationHospital Pharmacy Transformation Plan
Hospital Pharmacy Transformation Plan Introduction In June 2014, Lord Carter of Coles was appointed to the position of Chair of a new NHS Procurement & Efficiency Board to direct the NHS Procurement &
More informationWOLVERHAMPTON CLINICAL COMMISSIONING GROUP QUALITY & SAFETY COMMITTEE
Wolverhampton Clinical Commissioning Group WOLVERHAMPTON CLINICAL COMMISSIONING GROUP QUALITY & SAFETY COMMITTEE Minutes of the Quality and Safety Committee Meeting held on Tuesday 12 th May 2015 Commencing
More informationPHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives
PHARMACEUTICAL REPRESENTATIVE POLICY VEMBER 2017 This policy supersedes all previous policies for Medical Representatives Policy title Pharmaceutical Representative Policy Policy PHA39 reference Policy
More informationIs Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better?
Is Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better? Vanessa Burgess, Assistant Director, Medicines & LTCs, NHS Lambeth Clinical Commissioning Group;
More informationMedicines Management Policy
Medicines Management Policy Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Medicines Management Policy The Southern HSC Trust recognises that almost all patients
More informationMartina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist
Policy on Pharmacological Therapies Practice Guidance Note The use of Oral Anti-Cancer Medicines and Oral Methotrexate within - V03 V03 - Issued Issue 1 Dec 15 Planned review December 2018 PPT-PGN 09 Part
More informationSummary note of the meeting on 9 November 2017
UK Advisory Forum - Wales Summary note of the meeting on 9 November 2017 Attendees Terence Stephenson, Chair Stephen Burnett, GMC - Council Member for Wales David Bailey, BMA Cymru Wales Kate Chamberlain,
More informationCCG Policy for Working with the Pharmaceutical Industry
CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry
More informationGPs apply for inclusion in the NI PMPL and applications are reviewed against criteria specified in regulation.
Policy for the Removal of Doctors from the NI Primary Medical Performers List (NIPMPL) where they have not provided primary medical services in the HSCB area in the Preceding 24 Months Context GPs cannot
More informationReview of Follow-up Outpatient Appointments Hywel Dda University Health Board. Audit year: Issued: October 2015 Document reference: 491A2015
Review of Follow-up Outpatient Appointments Hywel Dda University Health Board Audit year: 2014-15 Issued: October 2015 Document reference: 491A2015 Status of report This document has been prepared as part
More informationCCIG(17)02 - Draft Minutes
All Wales Critical Care Implementation Group Agenda Tuesday 6 th September 2016, 2.00-4.00pm Caerdydd 3, Welsh Government, Cathays Park, Cardiff VC dial 521971 from NHS Videoconferencing Network 1. Welcome
More informationLincolnshire County Council Officers: Professor Derek Ward (Director of Public Health) and Sally Savage (Chief Commissioning Officer)
Agenda Item 5 1 LINCOLNSHIRE HEALTH AND WELLBEING BOARD PRESENT: COUNCILLOR MRS S WOOLLEY (CHAIRMAN) Lincolnshire County Council: Councillors C N Worth (Executive Councillor Culture and Emergency Services),
More information5.3: POLICY FOR THE MANAGEMENT OF REQUESTS FOR MEDICINES VIA PEER APPROVED CLINICAL SYSTEM (PACS) TIER 2
NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 5: NON-FORMULARY PROCESSES 5.3: POLICY FOR THE MANAGEMENT OF REQUESTS FOR MEDICINES VIA PEER APPROVED CLINICAL SYSTEM
More informationNon Executive Director. Named Professional for Safeguarding and Welfare of Children. Interim Chief Executive Officer
WELSH AMBULANCE SERVICES NHS TRUST Minutes of a meeting of the Clinical Governance Committee of the Welsh Ambulance Services NHS Trust held on 13 May 2010 at HQ, St Asaph, Vantage Point House, Cwmbran
More informationReconciliation of Medicines on Admission to Hospital
Reconciliation of Medicines on Admission to Hospital Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For
More informationAntimicrobial Stewardship Program in the Nursing Home
Antimicrobial Stewardship Program in the Nursing Home CAHF San Bernardino/Riverside Chapter May 19 th, 2016 Presented by Robert Jackson, Pharm.D. Pharmaceutical Consultant II, Specialist CDPH Licensing
More informationPublic health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36
Healthcare-associated infections: prevention ention and control Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36 NICE 2017. All rights reserved. Subject to Notice of rights
More informationPharmacy Department PRE-REGISTRATION TRAINEE PHARMACIST INFORMATION PACK
Pharmacy Department PRE-REGISTRATION TRAINEE PHARMACIST INFORMATION PACK 2 INDEX 1. Chelsea and Westminster Hospital 3 2. The Pharmacy 3 3. Services 3 4. Education and Training 5 5. Miscellaneous 5.1 Social
More informationTaranaki District Health Board
Taranaki District Health Board Current Status: 15 October 2013 The following summary has been accepted by the Ministry of Health as being an accurate reflection of the Certification Audit conducted against
More information